ArticleScientific reports2025
Lymphocyte trajectories as prognostic indicators in intracerebral hemorrhage: a MIMIC-IV cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dynamic inflammatory markers as predictors of 90-day outcomes in spontaneous intracerebral hemorrhage.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To examine the association between lymphocyte count trajectories and clinical outcomes in patients with spontaneous intracerebral hemorrhage (ICH) using data from the MIMIC-IV database. Patients with spontaneous ICH and at least two lymphocyte count measurements within the first 7 days of ICU admission were identified from the MIMIC-IV database. Latent growth mixture modeling was used to determine distinct lymphocyte trajectory groups. Kaplan-Meier survival curves and Cox proportional hazards models were employed to assess associations with mortality. Clinical characteristics and ICU length of stay were also compared between trajectory classes. A total of 841 patients were included. Two distinct lymphocyte trajectory classes were identified: Class 1 ("Increasing lymphocyte count") and Class 2 ("Decreasing lymphocyte count"). Kaplan-Meier analysis revealed significantly lower survival in Class 2 (p = 0.00046). Cox regression confirmed a higher mortality risk in Class 2 compared to Class 1. Patients in Class 2 also had significantly longer ICU stays (mean: 29.83 vs. 18.34 days, p < 0.01) and worse clinical outcomes. Subgroup analyses indicated that age, sex, BMI, diabetes status, and Glasgow Coma Scale (GCS) scores were associated with trajectory classification and mortality risk. Lymphocyte count trajectories are prognostically significant in patients with ICH. A decreasing lymphocyte trend is associated with higher mortality and prolonged ICU stays. Early identification of these patterns may improve risk stratification and guide targeted interventions. Further studies should explore underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.